JGH vs NAN
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JGH exhibits severe fundamental weakness, highlighted by a critical Piotroski F-Score of 1/9, indicating poor financial health. The fund is currently trading at a significant premium ($12.68) relative to its growth-based intrinsic value of $8.26. Furthermore, the dividend payout ratio of 104.48% suggests that the 9.79% yield is unsustainable and may be funded through return of capital. Combined with a 0/100 technical trend, the outlook is bearish.
The fund exhibits significant financial fragility, highlighted by a weak Piotroski F-Score of 3/9 and a deeply negative profit margin of -80.39%. While the dividend yield remains attractive at 7.53%, the deterministic health indicators and a very bearish technical trend (10/100) suggest a lack of operational momentum. The asset is trading at a slight premium to book value (P/B 1.06), but severe liquidity concerns (Current Ratio 0.25) and insider selling outweigh the long-term price appreciation.
Compare Another Pair
Related Comparisons
JGH vs NAN: Head-to-Head Comparison
This page compares Nuveen Global High Income Fund (JGH) and Nuveen New York Quality Municipal Income Fund (NAN) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.